Treatment of Glioblastoma Multiforme with High Doses of Carmustine Intracavitary, in an Infant

Overview

Journal Childs Nerv Syst

Specialty Pediatrics

Date 2011 Dec 30

PMID 22205534

Authors

Monica Rivero-Garvia

J Marquez-Rivas

A B Rueda-Torres

D Pascual-Argente

G Ramirez

Affiliations

Soon will be listed here.

References

Bock H, Cohnen J, Keric N, Kantelhardt S, Giese A . Occlusion of surgical opening of the ventricular system with fibrinogen-coated collagen fleece: a case collection study. Acta Neurochir (Wien). 2011; 153(3):533-9. PMC: 3040806. DOI: 10.1007/s00701-010-0923-z. View

Dufour C, Grill J, Lellouch-Tubiana A, Puget S, Chastagner P, Frappaz D . High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol. Eur J Cancer. 2006; 42(17):2939-45. DOI: 10.1016/j.ejca.2006.06.021. View

Marquez-Rivas J, Ramirez G, Ollero-Ortiz A, Gimenez-Pando J, Emmerich J, Quiroga-Cantero E . Initial experience involving treatment and retreatment with carmustine wafers in combination with oral temozolomide: long-term survival in a child with relapsed glioblastoma multiforme. J Pediatr Hematol Oncol. 2010; 32(5):e202-6. DOI: 10.1097/MPH.0b013e3181e0d16b. View

Olivi A, Grossman S, Tatter S, Barker F, Judy K, Olsen J . Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial. J Clin Oncol. 2003; 21(9):1845-9. DOI: 10.1200/JCO.2003.09.041. View

Westphal M, Ram Z, Riddle V, Hilt D, Bortey E . Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Acta Neurochir (Wien). 2006; 148(3):269-75. DOI: 10.1007/s00701-005-0707-z. View

Vredenburgh J, Desjardins A, Reardon D, Friedman H . Experience with irinotecan for the treatment of malignant glioma. Neuro Oncol. 2008; 11(1):80-91. PMC: 2718962. DOI: 10.1215/15228517-2008-075. View

Stupp R, Hegi M, Mason W, van den Bent M, Taphoorn M, Janzer R . Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009; 10(5):459-66. DOI: 10.1016/S1470-2045(09)70025-7. View

Bock H, Puchner M, Lohmann F, Schutze M, Koll S, Ketter R . First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience. Neurosurg Rev. 2010; 33(4):441-9. PMC: 2936684. DOI: 10.1007/s10143-010-0280-7. View

Westphal M, Hilt D, Bortey E, Delavault P, Olivares R, Warnke P . A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol. 2003; 5(2):79-88. PMC: 1920672. DOI: 10.1093/neuonc/5.2.79. View

10.

Spiegel B, Esrailian E, Laine L, Chamberlain M . Clinical impact of adjuvant chemotherapy in glioblastoma multiforme : a meta-analysis. CNS Drugs. 2007; 21(9):775-87. DOI: 10.2165/00023210-200721090-00006. View